Cytogenetic features in primary myelodysplastic syndrome Egyptian patients

Karyotype is the most important diagnostic and prognostic parameter in myelodysplastic syndromes (MDS) and is abnormal in approximately 50% of patients. We emphasized the importance of chromosomal analysis and reported the most frequent cytogenetic abnormalities in 50 MDS (29 males (58%) and 21 fema...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Yasser Elnahass, Lamiaa Youssif
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Elsevier 2018-03-01
Seri Bilgileri:Journal of Advanced Research
Konular:
Online Erişim:http://www.sciencedirect.com/science/article/pii/S2090123218300225
_version_ 1828927653421252608
author Yasser Elnahass
Lamiaa Youssif
author_facet Yasser Elnahass
Lamiaa Youssif
author_sort Yasser Elnahass
collection DOAJ
description Karyotype is the most important diagnostic and prognostic parameter in myelodysplastic syndromes (MDS) and is abnormal in approximately 50% of patients. We emphasized the importance of chromosomal analysis and reported the most frequent cytogenetic abnormalities in 50 MDS (29 males (58%) and 21 females (42%), median age: 57.5 years) Egyptian patients using conventional banding analysis (CBA). Karyotype description was conducted according to the International System for Human Cytogenetic Nomenclature (ISCN, 2013). Patients were diagnosed based on complete history, bone marrow (BM) aspirate, peripheral blood (PBL) examination, and Iron stain. MDS with multilineage dysplasia (MDS-MLD) was the most frequently encountered subtype; 19/50 (38%) followed by MDS with single lineage dysplasia (MDS-SLD); 11/50 (22%). 27/50 patients (54%) showed a normal karyotype while 23 patients (46%) showed clonal nonrandom chromosomal abnormalities. Most patients with MDS with excess blasts-II (MDS-EB-II) showed abnormal karyotype (3/4; 75%) followed by MDS-EB-I (3/5, 60%) and MDS-MLD (10/19, 53%). Among 50 primary MDS patients; 14/50 (28%) had a single chromosomal abnormality, 3/50 (6%) had double chromosomal abnormality, and 6/50 (12%) had complex karyotype. Male sex was more frequently associated with higher IPSS prognostic risk categories than female gender. The most common single chromosomal abnormalities were −5/del5q; 7/50 (14%) patients followed by −7; 4/50 (8%) patients. +8, del20q and delY were each detected in 1/50 patient (2%). Abnormalities of chromosome 5 (−5/del5q) as a single chromosomal abnormality was the most frequent chromosomal abnormality among Egyptian primary MDS patients followed by complex karyotype. Cytogenetic characteristics of MDS Egyptian patients were similar to North African and European patients. Karyotype offers useful information in establishing accurate diagnosis and male gender is an important predisposing factor that can predict worse prognosis in MDS patients.
first_indexed 2024-12-13T23:52:50Z
format Article
id doaj.art-db183aba02b64dd1af8136e88a6981f8
institution Directory Open Access Journal
issn 2090-1232
2090-1224
language English
last_indexed 2024-12-13T23:52:50Z
publishDate 2018-03-01
publisher Elsevier
record_format Article
series Journal of Advanced Research
spelling doaj.art-db183aba02b64dd1af8136e88a6981f82022-12-21T23:26:43ZengElsevierJournal of Advanced Research2090-12322090-12242018-03-0110C778310.1016/j.jare.2018.02.002Cytogenetic features in primary myelodysplastic syndrome Egyptian patientsYasser Elnahass0Lamiaa Youssif1Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, EgyptDepartment of Molecular Diagnostics, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Menoufia Province, EgyptKaryotype is the most important diagnostic and prognostic parameter in myelodysplastic syndromes (MDS) and is abnormal in approximately 50% of patients. We emphasized the importance of chromosomal analysis and reported the most frequent cytogenetic abnormalities in 50 MDS (29 males (58%) and 21 females (42%), median age: 57.5 years) Egyptian patients using conventional banding analysis (CBA). Karyotype description was conducted according to the International System for Human Cytogenetic Nomenclature (ISCN, 2013). Patients were diagnosed based on complete history, bone marrow (BM) aspirate, peripheral blood (PBL) examination, and Iron stain. MDS with multilineage dysplasia (MDS-MLD) was the most frequently encountered subtype; 19/50 (38%) followed by MDS with single lineage dysplasia (MDS-SLD); 11/50 (22%). 27/50 patients (54%) showed a normal karyotype while 23 patients (46%) showed clonal nonrandom chromosomal abnormalities. Most patients with MDS with excess blasts-II (MDS-EB-II) showed abnormal karyotype (3/4; 75%) followed by MDS-EB-I (3/5, 60%) and MDS-MLD (10/19, 53%). Among 50 primary MDS patients; 14/50 (28%) had a single chromosomal abnormality, 3/50 (6%) had double chromosomal abnormality, and 6/50 (12%) had complex karyotype. Male sex was more frequently associated with higher IPSS prognostic risk categories than female gender. The most common single chromosomal abnormalities were −5/del5q; 7/50 (14%) patients followed by −7; 4/50 (8%) patients. +8, del20q and delY were each detected in 1/50 patient (2%). Abnormalities of chromosome 5 (−5/del5q) as a single chromosomal abnormality was the most frequent chromosomal abnormality among Egyptian primary MDS patients followed by complex karyotype. Cytogenetic characteristics of MDS Egyptian patients were similar to North African and European patients. Karyotype offers useful information in establishing accurate diagnosis and male gender is an important predisposing factor that can predict worse prognosis in MDS patients.http://www.sciencedirect.com/science/article/pii/S2090123218300225MDSGenderChromosomal abnormalities−5/5q-MDS-MLDMDS-EB-II
spellingShingle Yasser Elnahass
Lamiaa Youssif
Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
Journal of Advanced Research
MDS
Gender
Chromosomal abnormalities
−5/5q-
MDS-MLD
MDS-EB-II
title Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
title_full Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
title_fullStr Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
title_full_unstemmed Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
title_short Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
title_sort cytogenetic features in primary myelodysplastic syndrome egyptian patients
topic MDS
Gender
Chromosomal abnormalities
−5/5q-
MDS-MLD
MDS-EB-II
url http://www.sciencedirect.com/science/article/pii/S2090123218300225
work_keys_str_mv AT yasserelnahass cytogeneticfeaturesinprimarymyelodysplasticsyndromeegyptianpatients
AT lamiaayoussif cytogeneticfeaturesinprimarymyelodysplasticsyndromeegyptianpatients